Upgrade to SI Premium - Free Trial

JPMorgan Double Downgrades Fulcrum Therapeutics (FULC) to Underweight

June 2, 2026 4:26 PM
JPMorgan downgraded Fulcrum Therapeutics (NASDAQ: FULC) from Overweight ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades